RORC and cancer: Although previous studies showed that UA can act as RORγt inhibitor in immune cells such as Th17 cells (Xu et al., 2011; Baek et al., 2014), our study here provides for the first-time evidence that UA displays RORγ antagonism activity in cancer cells.